321 related articles for article (PubMed ID: 35845934)
1. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and
Darabi F; Saidijam M; Nouri F; Mahjub R; Soleimani M
Biomed Res Int; 2022; 2022():6253978. PubMed ID: 35845934
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
3. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
Zheng G; Zheng M; Yang B; Fu H; Li Y
Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
[TBL] [Abstract][Full Text] [Related]
5. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer.
Pindiprolu SKSS; Krishnamurthy PT; Dev C; Chintamaneni PK
Chem Phys Lipids; 2021 Mar; 235():105033. PubMed ID: 33385372
[TBL] [Abstract][Full Text] [Related]
6. Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line.
Kostrzewa T; Nowak I; Feliczak-Guzik A; Drzeżdżon J; Jacewicz D; Górska-Ponikowska M; Kuban-Jankowska A
Int J Nanomedicine; 2023; 18():2507-2523. PubMed ID: 37197025
[TBL] [Abstract][Full Text] [Related]
7. Preparation, Statistical Optimization and Characterization of Propolis-Loaded Solid Lipid Nanoparticles Using Box-Behnken Design.
Taherzadeh S; Naeimifar A; Mehrabani Yeganeh E; Esmaili Z; Mahjoub R; Akbari Javar H
Adv Pharm Bull; 2021 Feb; 11(2):301-310. PubMed ID: 33880352
[No Abstract] [Full Text] [Related]
8. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells.
Pindiprolu SKSS; Chintamaneni PK; Krishnamurthy PT; Ratna Sree Ganapathineedi K
Drug Dev Ind Pharm; 2019 Feb; 45(2):304-313. PubMed ID: 30348020
[TBL] [Abstract][Full Text] [Related]
9. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.
Sohaib M; Shah SU; Shah KU; Shah KU; Khan NR; Irfan MM; Niazi ZR; Alqahtani AA; Alasiri A; Walbi IA; Mahmood S
Biomed Res Int; 2022; 2022():7792180. PubMed ID: 35971450
[TBL] [Abstract][Full Text] [Related]
11. Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
Rawal S; Gupta P; Bhatnagar P; Yadav HN; Dinda AK
Comb Chem High Throughput Screen; 2022; 25(10):1695-1706. PubMed ID: 35718970
[TBL] [Abstract][Full Text] [Related]
12. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.
Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M
AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073
[TBL] [Abstract][Full Text] [Related]
13. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
[TBL] [Abstract][Full Text] [Related]
14. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
15. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
17. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin.
Jain A; Kesharwani P; Garg NK; Jain A; Jain SA; Jain AK; Nirbhavane P; Ghanghoria R; Tyagi RK; Katare OP
Colloids Surf B Biointerfaces; 2015 Oct; 134():47-58. PubMed ID: 26142628
[TBL] [Abstract][Full Text] [Related]
18. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
[No Abstract] [Full Text] [Related]
19. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
20. α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line.
Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
Assay Drug Dev Technol; 2023; 21(8):345-356. PubMed ID: 38010987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
